ArticleScientific reports2021
The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers.
Stijn Moens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it